Blog

Future Fifty: joining forces to drive forward positive change

We are immensely excited and proud to have been selected for Tech Nation's 2020 Future Fifty cohort, alongside 28 fellow UK tech trailblazers.

It’s been an honour witnessing the impressive growth of the UK tech scene over the past decade. Before joining Benevolent in 2018, I spent five years helping the Government harness the potential of technology: maximising the growth of the digital economy and serving as the UK’s first Minister for Internet Security and Safety. In the years since thousands of fast-growth startups have flourished in Britain, each founded with the hope that our world can be improved through technology. It is gratifying to see that so many fellow members of this year's Future Fifty cohort are inspired and committed to the dream of ‘what can be’, and are channelling this into innovations that fundamentally change things for the better.

Tech Nation’s Future Fifty was founded with the purpose of bringing together the country’s most successful tech businesses to build a powerful network of peers. With the help of the tech community, the programme supports companies in achieving their global ambitions, creating jobs and opportunities across the UK, and inspiring the next generation of tech entrepreneurs, founders and businesses. Community and knowledge sharing helped establish the UK as one of the leading locations to start, nurture and grow or tech-enabled disruptive businesses, with a number of high profile success stories listing on the LSE.

In these challenging times, we have seen the global scientific community mobilise to respond to the deadly disease ravaging our planet, and have once again witnessed how community serves as a powerful vehicle for transformation and hope. Finally, as UK tech journeys into a new phase in a post-Brexit world, it is more important than ever that we join forces with like-minded industry experts to drive forward towards a more purposeful future.

I am inspired by the uncompromising determination and passion of the talented team we have assembled here at Benevolent.  We are united by our mission to push the boundaries of technology and to use AI and machine learning to develop more effective medicines for patients in areas of significant unmet need. Experts from diverse technology and scientific disciplines such as machine learning, drug discovery and engineering work together towards a common goal: a future in which no disease goes untreated. Having Future Fifty by our side for the journey ahead will undoubtedly help us further deliver against this vision.

The saying goes that the whole is greater than the sum of its parts. This is no doubt true of the UK tech scene: together, we make up the number-three tech startup ecosystem in the world. Together, we have secured our place at the heart of the biggest story of 21st-century growth and promise. Together, we are working on solutions to pressing global challenges that will impact quality of life and improve society for all.

Joanna Shields, CEO

More Posts

You Might Also Like

News
ACTT-2 trial results published in the New England Journal of Medicine validate baricitinib’s efficacy in combination with remdesivir in hospitalised COVID-19 patients
Peer-reviewed data from the ACTT-2 further validate BenevolentAI’s hypothesis for baricitinib as a potential COVID-19 treatment.
Jan 15, 2021
Blog
Joanna Shields speaks at the Global Partnership on Artificial Intelligence
BenevolentAI CEO Joanna Shields opened the final plenary of the Global Partnership on Artificial Intelligence (GPAI) summit with a powerful message on the future of AI.
Dec 11, 2020
Blog
BenevolentAI wins Innovation Award at 2020 Scrip Awards
BenevolentAI wins the Innovation Award at the prestigious 2020 Scrip Awards for our work in artificial intelligence applied drug discovery.
Dec 11, 2020
Intern at BenevolentAI part II: what to expect from your internship
What makes the best tech internships? Learn about what our 2020 interns have been up to, and how interning at Benevolent helped their career development.
Dec 2, 2020
Blog
Intern at BenevolentAI part I: meet our 2020 intern cohort
What impactful work did our interns get up to across Engineering, Data Science, ML and business operations this summer? Get to know them and their work in our tech internships blog.
Nov 26, 2020
News
FDA grants Emergency Use Authorisation for baricitinib in hospitalised COVID-19 patients nine months after initial hypothesis was published by BenevolentAI
BenevolentAI scientists first identified baricitinib as a potential treatment for COVID-19 in early February 2020 using Benevolent's AI tools and biomedical knowledge graph.
Nov 20, 2020